Urolithin D
Urolithin D is a competitive, reversible EphA receptor antagonist derived from ellagitannin gut metabolism. It suppresses EphA2 phosphorylation in prostate cancer cells and reduces triglyceride accumulation in adipocyte and hepatocyte cultures, making it a valuable research tool for studying cancer signaling and metabolic disorders such as NAFLD.
Product Specifications
CAS Number
131086-98-1
Field of Research
Epigenetics & Chromatin, Metabolism Research, Molecular Biology, Signal Transduction
Purity
99.87% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (15.37 mM) ; DMSO:100 mg/mL (384.32 mM)
Smiles
O=C1OC=2C (O) =C (O) C=CC2C3=CC (O) =C (O) C=C13
Molecular Formula
C13H8O6
Molecular Weight
260.2
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
043133-Biotin 200 µL
TOPBP1, ID (S1138) (TOPBP1, KIAA0259, DNA topoisomerase 2-binding protein 1, DNA topoisomerase II-beta-binding protein 1, DNA topoisomerase II-binding protein 1) (Biotin) discontinued
Sign In for Pricing
View Details 